In this fifth episode, I had the pleasure of interviewing Benedikt von Thüngen, CEO and founder of London based Sanome. Benedikt previously founded a couple of other startups amongst which Speechmatics. Sanome is building a human digital twin and uses AI to build combination biomarker diagnostics to detect the earliest signs of disease. Sanome already proved that its model could reduce by two thirds the number of required patients in a clinical trial. The company also recently signed a partnership with a UK care home provider to identify an early warning system.
